Skip to main content
Journal ArticleOPEN ACCESS

Difference in Therapeutic Response Between Basal and Nonbasal Triple-Negative Breast Cancers

  • Bertucci F
  • Finetti P
  • Viens P
  • et al.
The Oncologist (2013) 18(9) 1060-1061
DOI: 10.1634/theoncologist.2013-0121
3Citations
Citations of this article
10Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

This study, which nicely complements a study recently published in The Oncologist, shows for the first time that triple-negative breast cancers are much more heterogeneous than basal breast cancers regarding the response to chemotherapy and the probability of response to molecularly targeted therapies.

Cite

CITATION STYLE

APA

Bertucci, F., Finetti, P., Viens, P., & Birnbaum, D. (2013). Difference in Therapeutic Response Between Basal and Nonbasal Triple-Negative Breast Cancers. The Oncologist, 18(9), 1060–1061. https://doi.org/10.1634/theoncologist.2013-0121

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free